Bosentan monohydrate is an endothelin receptor antagonist, the endothelin molecule leads to an increase in blood pressure by constricting blood vessels. Bosentan acts as a vasodilator by inhibiting the function of endothelin molecules and is used to improve pulmonary artery hypertension, as well as improve exercise ability and prevent the deterioration of the patient's condition.